Skip to contentFOEHR MATTHEW W — LIGAND PHARMACEUTICALS INC insider: 399 transactions · InsiderLensFOEHR MATTHEW W
- President and CEO at OmniAb, Inc. · on record since Dec 30, 2022
- Sr. VP Technical Operations at CONNETICS CORP · on record since Jun 1, 2004
- Director at OmniAb, Inc. · on record since Apr 7, 2026
- President and COO at LIGAND PHARMACEUTICALS INC · on record since Jun 30, 2015
- Director at Viking Therapeutics, Inc. · on record since Apr 30, 2015
- Director at AIxCrypto Holdings, Inc. · on record since Jun 25, 2015
- Director at OmniAb, Inc. · on record since Sep 30, 2022
- Former Executive Officer at LIGAND PHARMACEUTICALS INC · on record since Nov 3, 2022
- CLO & Secretary at OmniAb, Inc. · on record since Sep 30, 2022
Insider trading activity of FOEHR MATTHEW W
- Transactions on record
- 399
- since Dec 1, 2003
- Open-market buys
- 26
- $8.4M
- Open-market sells
- 46
- $33M
- Companies traded
- 6
- last filing Apr 7, 2026
Figures computed from official regulatory filings — methodology.
Companies where FOEHR MATTHEW W has traded
- OmniAb, Inc.90 tx · $11.3M · Apr 7, 2026
- Viking Therapeutics, Inc.27 tx · $1.2M · Jan 5, 2026
- OmniAb, Inc.12 tx · Nov 3, 2022
- LIGAND PHARMACEUTICALS INC196 tx · $51.6M · Nov 3, 2022
- AIxCrypto Holdings, Inc.15 tx · $92.8K · Apr 23, 2020
- CONNETICS CORP59 tx · $1.6M · Jan 3, 2007
Track record of FOEHR MATTHEW W
Statistical track record
Free- Open-market buys
- 29
- Last buy
- May 24, 2024
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of FOEHR MATTHEW W
Co-insiders of FOEHR MATTHEW W
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
MAIER PAUL VAIxCrypto Holdings, Inc. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Apr 7, 2026 | Sell | -19,244 | 1.49 USD | $28.7K | SEC |
| Apr 7, 2026 | Exercise | 36,459 | 0.00 USD | $0 | SEC |
| Apr 7, 2026 | ExerciseD | -36,459 | 0.00 USD | $0 | SEC |
| Feb 18, 2026 | ExerciseD | -58,333 | 0.00 USD | $0 | SEC |
| Feb 18, 2026 | AwardD | 156,250 | 0.00 USD | $0 | SEC |
| Feb 18, 2026 | Exercise | 58,333 | — | — | SEC |
| Feb 18, 2026 | Sell | -30,843 | 1.71 USD | $52.7K | SEC |
| Feb 18, 2026 | AwardD | 1,562,500 | 0.00 USD | $0 | SEC |
| Feb 17, 2026 | Exercise | 36,458 | 0.00 USD | $0 | SEC |
| Feb 17, 2026 | ExerciseD | -36,458 | 0.00 USD | $0 | SEC |
| Feb 17, 2026 | Sell | -20,754 | 1.70 USD | $35.3K | SEC |
| Jan 5, 2026 | Sell | -16,000 | 35.11 USD | $561.8K | SEC |
| Jan 5, 2026 | ExerciseD | -16,000 | 0.00 USD | $0 | SEC |
| Jan 5, 2026 | Exercise | 16,000 | 3.33 USD | $53.3K | SEC |
| Jan 5, 2026 | AwardD | 20,400 | 0.00 USD | $0 | SEC |
| Jan 5, 2026 | Award | 3,150 | 0.00 USD | $0 | SEC |
| Dec 9, 2025 | Exercise | 26,554 | 0.00 USD | $0 | SEC |
| Dec 9, 2025 | ExerciseD | -26,554 | 0.00 USD | $0 | SEC |
| Dec 9, 2025 | Sell | -13,666 | 1.96 USD | $26.8K | SEC |
| Aug 26, 2025 | Award | 540,540 | 1.85 USD | $1M | SEC |
| Apr 14, 2025 | Exercise | 20,786 | 8.00 USD | $166.3K | SEC |
| Apr 14, 2025 | ExerciseD | -20,786 | 0.00 USD | $0 | SEC |
| Apr 7, 2025 | ExerciseD | -36,458 | 0.00 USD | $0 | SEC |
| Apr 7, 2025 | Exercise | 36,458 | 0.00 USD | $0 | SEC |
| Apr 7, 2025 | Sell | -19,382 | 2.00 USD | $38.8K | SEC |